Breast Milk Proteome: Changes in the Different Stages of Lactation and Impacts of Gestational Diabetes Mellitus and Body Mass Index
Mol Nutr Food Res. 2025 Sep 1:e70225. doi: 10.1002/mnfr.70225. Online ahead of print.
Published on September 2, 2025
ABSTRACT
Breast milk proteome comprises hundreds of bioactive proteins supporting infant development. The extent to which maternal metabolic conditions modify the proteome is poorly known. This study investigates proteome evolution from colostrum to mature milk and examines the impacts of maternal gestational diabetes mellitus (GDM) and BMI on the proteome. We analyzed the proteome by data-independent acquisition (DIA)-based LC-MS/MS from colostrum and mature milk samples collected from mothers (n = 47) with varying BMI values and with (n = 11) or without (n = 36) GDM. We identified 3496 proteins, of which 1055 were differentially abundant between colostrum and mature milk. Colostrum was enriched in proteins related to MHC II antigen response, intestinal IgA, adhesion, and glycosylation, while mature milk showed enrichment in lipid biosynthesis, protein translation, and degradation. In mature milk, mothers with both GDM and higher BMI had increased levels of proteins related to HDL formation. Proteins supporting the maturation of the naive gut immune system were prevalent in colostrum, while those prevalent in mature milk reflected the mammary gland’s effort in biosynthesis. Both BMI and GDM have measurable effects on the breast milk proteome. The clinical significance of these findings on a child’s future health needs to be clarified.
PMID:40891102 | DOI:10.1002/mnfr.70225
Latest Publications
- Testosterone Exposure During Fetal Masculinization Programming Window Determines the Kidney Size in Adult Mice
- Genomic history of early dogs in Europe
- miR-199a-3p Promotes Adipogenic Differentiation to Aggravate Steroid-Induced Osteonecrosis of Femoral Head via the ITGB8/FAK-ERK/RUNX2 Pathway
- Macrophages restrict tumor immune infiltration by controlling collagen topography
- Fluorine-18-Labeled Nucleotide Analogs Targeting Ecto-5′-Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors